| Id |
Subject |
Object |
Predicate |
Lexical cue |
db_id |
| 357 |
0-11 |
ChemicalEntity |
denotes |
Apomorphine |
MESH:D001058 |
| 358 |
42-61 |
DiseaseOrPhenotypicFeature |
denotes |
Parkinson's disease |
MESH:D010300 |
| 359 |
63-74 |
ChemicalEntity |
denotes |
Apomorphine |
MESH:D001058 |
| 360 |
89-106 |
ChemicalEntity |
denotes |
dopaminergic drug |
MESH:D004298 |
| 361 |
138-157 |
DiseaseOrPhenotypicFeature |
denotes |
Parkinson's disease |
MESH:D010300 |
| 362 |
273-292 |
DiseaseOrPhenotypicFeature |
denotes |
Parkinson's disease |
MESH:D010300 |
| 363 |
327-338 |
ChemicalEntity |
denotes |
apomorphine |
MESH:D001058 |
| 364 |
493-504 |
ChemicalEntity |
denotes |
apomorphine |
MESH:D001058 |
| 365 |
590-598 |
ChemicalEntity |
denotes |
levodopa |
MESH:D007980 |
| 366 |
608-619 |
ChemicalEntity |
denotes |
apomorphine |
MESH:D001058 |
| 367 |
678-686 |
OrganismTaxon |
denotes |
patients |
NCBITaxon:9606 |
| 368 |
745-756 |
ChemicalEntity |
denotes |
apomorphine |
MESH:D001058 |
| 369 |
827-835 |
OrganismTaxon |
denotes |
patients |
NCBITaxon:9606 |
| 370 |
930-947 |
ChemicalEntity |
denotes |
dopamine agonists |
MESH:D018491 |
| 371 |
951-966 |
ChemicalEntity |
denotes |
COMT inhibitors |
MESH:D065098 |
| 372 |
1055-1066 |
ChemicalEntity |
denotes |
apomorphine |
MESH:D001058 |
| 373 |
1174-1185 |
ChemicalEntity |
denotes |
apomorphine |
MESH:D001058 |
| 374 |
1248-1256 |
ChemicalEntity |
denotes |
levodopa |
MESH:D007980 |
| 375 |
1265-1276 |
DiseaseOrPhenotypicFeature |
denotes |
dyskinesias |
MESH:D004409 |
| 376 |
1316-1327 |
ChemicalEntity |
denotes |
apomorphine |
MESH:D001058 |
| 377 |
1407-1432 |
DiseaseOrPhenotypicFeature |
denotes |
psychiatric complications |
MESH:D001523 |
| 378 |
1505-1516 |
ChemicalEntity |
denotes |
apomorphine |
MESH:D001058 |
| 379 |
1542-1561 |
DiseaseOrPhenotypicFeature |
denotes |
Parkinson's disease |
MESH:D010300 |
